Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

Summary

RATIONALE: Sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well sorafenib tosylate works in treating patients with liver cancer that can be removed by surgery.

Timeline

Start

2010-05

Primary completion

2012-06

Completion

—

Drugs

Indications